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We report that ultra-small, monodisperse, water-dispersible magnetite (Fe3O4) nanoparticles can be
synthesized by a facile one-pot approach using trisodium citrate as crystal grain growth inhibitor and
stabilizer in polyol solution. The resultant Fe3O4 nanoparticles exhibit an excellent long-term colloidal
stability in various buffer solutions without any modification. They are also superparamagnetic at room
temperature and their magnetic property relies heavily on their size. Due to the low magnetization and
good water-dispersibility, the 1.9 nm-sized Fe3O4 nanoparticles reveal a low r2/r1 ratio of 2.03 (r1 ¼
1.415 mM1 s1, r2 ¼ 2.87 mM1 s1), demonstrating that they can be efficient T1 contrast agents. On
the other hand, because of the excellent magnetic responsivity, the 13.8 nm-sized Fe3O4 nanoparticles
can be readily modified with nitrilotriacetic acid and used to separate the protein simply with the
assistance of a magnet. In addition, these Fe3O4 nanoparticles may be useful in other fields, such as
hyperthermia treatment of cancer and targeted drug delivery based on their size-dependent magnetic
property and excellent stability.1 Introduction
Magnetic nanoparticles have shown great potential in
biomedical applications such as biomolecular separation, tar-
geted drug delivery, hyperthermia treatment of cancer, water
treatment and magnetic resonance imaging (MRI) as contrast
agents.1–7 Among various magnetic nanoparticles, Fe3O4 nano-
particles have been extensively investigated due to their excel-
lent biocompatibility and magnetic property.8 However, the
magnetic property of Fe3O4 nanoparticles is strongly dependent
on their size.9 Themagnetic moment of Fe3O4 nanoparticles will
decline rapidly as their size decreases due to the reduction in
the volume magnetic anisotropy and spin disorders on the
surface of the nanoparticles, which is very benecial to suppress
the T2 effect and therefore maximize the T1 contrast effect.10,11
Recently, small-sized Fe3O4 nanoparticles such as ultra-small
particles of iron oxide (USPIO) (5 nm) used as T1 contrast
agents have been reported.12,13 More recently, the thermal
decomposition of different iron precursors in nonpolar organicMaterials, Xiamen University, Xiamen,
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Chemistry 2013solvents has been used to produce extremely small-sized iron
oxide nanoparticles (ESIONs) (<4 nm).14 However, Fe3O4 nano-
particles produced by this method are only organic-soluble due
to the capped hydrophobic surfactant ligands, which to some
extent limits their use in the biomedical eld, especially for
in vivo applications.14,15 To address this issue, post-synthetic
modication is usually employed to offer them a hydrophilic
surface and aqueous dispersibility, including ligand exchange
and post-synthetic functionalization on the existing ligand
shell, both of which can not only make the process more
complicated but also result in larger hydrodynamic
diameters.16,17
Polyol-mediated synthesis is a versatile chemical approach to
prepare high-quality water-stable Fe3O4 nanoparticles. In this
method, polyols such as ethylene glycol (EG),18 diethylene glycol
(DEG),19 triethylene glycol (TREG),20 and poly-(ethylene glycol)
(PEG)21 oen act as a high-boiling solvent and reductant, as well
as a stabilizer to control the particle growth and prevent inter-
particle aggregating. Compared to the thermal decomposition
method, Fe3O4 nanoparticles prepared by this route exhibit
some water-dispersibility due to a hydrophilic coating.18,19
However, the polyol coating is not covalently linked on the
nanoparticle surface and therefore there is a relatively weak
interaction between polyols.22 When these nanoparticles are
introduced to the body, they usually exhibit poor long-term
stability due to the desorption of polyols, facilitating their













































View Article Onlinethese factors, long-term colloidal stability under physiological
conditions is desired to overcome these problems.
In this work, we report that ultra-small, monodisperse,
water-dispersible magnetite (Fe3O4) nanoparticles can be
synthesized by a facile one-pot approach. Biocompatible Na3Cit
was chosen because it can act as a crystal grain growth inhibitor
for the synthesis of smaller sized nanoparticles. In addition, the
three carboxylate groups of Na3Cit have strong coordination
affinity to Fe(III) ions. This may favor the attachment of citrate
groups on the surface of the Fe3O4 nanoparticles.18 Herein, the
Fe3O4 nanoparticles synthesized by Na3Cit are also intrinsically
stabilized with a layer of the hydrophilic ligands in situ, pre-
venting them from aggregating into large single crystals, which
is essential for their long-term stability in aqueous media
without any surface modications. Furthermore, we demon-
strate that the as-synthesized Fe3O4 nanoparticles are potential
magnetic carriers for protein separation and contrast-
enhancement agents for magnetic resonance imaging (MRI).
2 Experimental
2.1 Reagents and materials
Anhydrous sodium acetate (NaOAc), anhydrous ferric chloride
(FeCl3), diethylene glycol (DEG), ethanol (C2H5OH), trisodium
citrate (Na3Cit), NiCl2$6H2O, 1-[3-(dimethylamino)propyl]-3-ethyl-
carbodiimide hydrochloride (EDC), and N-hydroxysuccinimide
(NHS) were of analytical grade and were purchased from
Sinopharm Chemical Reagent Co., Ltd. (China). 3-(4,5-Dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT), phenyl-
methanesulfonyl uoride (PMSF) and isopropyl-1-thio-b-D-
galactopyranoside (IPTG) were obtained from Amresco (America).
Nitrilotriacetate (NTA) was purchased from Sigma (America). Dul-
becco's Modied Eagle's Medium (DMEM) was obtained from
Hyclon (America). Iron standard solution was purchased from
Merck Chemicals (Shanghai) Co. Ltd. All reagents were used
directly as received without further purication.
2.2 Synthesis of Fe3O4 nanoparticles
In a typical synthesis of 3.1 nm Fe3O4 nanoparticles, anhydrous
FeCl3 (4 mmol) was rst vigorously mixed with 40 mL of DEG to
form a clear solution. Then, Na3Cit (1.6 mmol) was added and
the mixture was heated at 80 C with stirring to form a clear
solution. Aer dissolving anhydrous NaOAc (12.0 mmol) in the
above solution, the mixture was transferred into a Teon-lined
stainless-steel autoclave (100 mL capacity) and sealed in air.
Following this, the autoclave was kept at 200 C for 6 h. Aer
being allowed to cool naturally to room temperature, the black
products were collected by centrifugation (12 000 rpm, 30 min)
and washed with ethanol three times. The obtained precipitate
was then dried at 60 C for further use. Furthermore, Fe3O4
nanoparticles with sizes of 1.9 nm, 4.2 nm, and 13.8 nm were
obtained at 200 C for 4 h, 10 h and 240 C for 6 h, respectively.
2.3 Stability tests
The pH-dependent stability was tested by adjusting the pH
value of the nanoparticle dispersion from 1.5 to 12 with 50 mM
HCl or 50 mM NaOH solution. The colloid stability study in2134 | Nanoscale, 2013, 5, 2133–2141various buffer solutions (Tris–HCl or NaCl) was started with the
preparation of buffer stock solution (100 mM). The as-synthe-
sized Fe3O4 nanoparticle suspension was added into the stock
solutions to reach four targeted concentrations (5, 10, 25 and
50 mM, respectively). The stock solution for PBS buffer (10)
was used as purchased, and the targeted concentrations for the
test were 0.5, 1, and 2, respectively. The hydrodynamic
sizes and z-potentials of the well mixed Fe3O4 nanoparticles
were studied by the dynamic light scattering (DLS) method at
room temperature.2.4 Characterization techniques
TEM images and SAED patterns were obtained on a JEOL JEM-
2100 (Tokyo, Japan) operated at an accelerating voltage of
200 kV. Samples for TEM and HR-TEM analysis were prepared
by spreading a drop of the as-synthesized Fe3O4 nanoparticle
dilute dispersion on copper grids coated with a carbon lm
followed by evaporation under ambient conditions. The XRD
patterns were collected between 20 and 80 (2q) degrees on an
X'pert PRO X-ray diffraction system (Almelo, Netherlands) with
a graphite monochromator and Cu Ka radiation (l ¼ 0.15406
nm). Grain size of the as-synthesized Fe3O4 nanoparticles was
calculated by the Debye–Scherrer equation25 from the reection
(311) peak. DLS measurements were performed with a Malvern
Instruments Zetasizer Nano Series Nano-ZS (Worcestershire,
United Kingdom) with Dispersion Technology Soware 5.03,
provided with a He/Ne laser of 633 nm wavelength. FTIR spectra
(4000–400 cm1) from KBr disks of the freeze-dried Fe3O4
nanoparticles were obtained on a Thermo Nicolet NEXUS 870
Fourier transform spectrometer (Waltham, America). TGA
analysis was performed on a TG209F1 thermogravimetric
analyzer (Netzsch, Germany). All measurements were taken
under a constant ow of air of 25 mL min1. The temperature
was increased at a pace of 10 C min1, starting from 30 up to
800 C. XPS spectra were measured using a PHI Quantum-2000
electron spectrometer (Ulvac-Phi, Japan) with 150 W mono-
chromatized Al Ka radiation (1486.6 eV). Field-dependent
magnetization (M–H curves) was measured on a VSM-7400
magnetometer (Lakeshore, America) at room temperature.
Fluorescent intensity was detected at an FLS 920 uorescence
spectrophotometer (Edinburgh, United Kingdom) with a Xe 900
lamp, and the excitation wavelength was 488 nm. The element
content of Fe was detected by a PE DRC-e inductively coupled
plasma mass spectrometry (ICP-MS, Perkin Elmer, America),
and the iron standard solution (100 mg L1) was used as a
standard control.2.5 MRI relaxation properties of iron oxide nanoparticles
MR relaxivities of the as-synthesized Fe3O4 nanoparticles were
measured using a small animal 7.0 T MR scanner (Varian,
America) with a 63/95 mm quad birdcage coil and gradient
strength up to 400 mT m1. An inversion recovery spin echo
sequence was used to measure T1. The measurement parame-
ters were as follows: TR¼ 6000 ms, TE¼ 10 ms, and TI¼ 20, 40,
80, 160, 320, 640, 1280 and 2560 ms, respectively. CPMGThis journal is ª The Royal Society of Chemistry 2013
Fig. 1 (A–D) TEM images of the, as-synthesized Fe3O4 nanoparticles with
diameters of 3.1 nm (A), 1.9 nm (B), 4.2 nm (C), and 13.8 nm (D), respectively. The
corresponding particle size distribution (insets) obtained by statistical analysis
over 200 particles. The inset in image (A) is the SAED of 3.1 nm-sized Fe3O4













































View Article Onlinesequence was used to measure T2, and its parameters were TR¼
5000 ms and TE ¼ 8, 16, 32, 64, 128 and 256 ms, respectively.
2.6 Cell viability
The cytotoxicity study was carried out by using the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
assay on human cervical carcinoma HeLa cells.14 Briey, HeLa
cells were seeded in 96-well plates at 5  103 cells per well in
DMEM medium and incubated at 37 C in a humidied atmo-
sphere with 5% CO2 for 12 h. The cells were then treated in
triplicate with fresh medium containing grade concentrations
(0.05–2.00 mg L1) of the nanoparticles prepared at 37 C for
12 h and 24 h, respectively. Cells treated with medium served
only as a negative control group. Aliquots of MTT (20 mL, 5 mg
mL1) were added to each of the wells for 4 h of incubation.
Aer the medium was removed, 150 mL of DMSO was then
added to each well and the plate was shaken gently for 15 min.
Absorbance was measured at 570 nm by using a Bio-Tek ELX800
spectrophotometric microplate reader (Vermont, America), and
the cell viability was expressed as a percentage relative to
untreated control cells. All experiments were performed three
times.
2.7 Fabrication of Fe3O4–NTA–Ni
2+ nanoparticles
The as-synthesized Fe3O4 nanoparticles (10 mg) were rstly
dispersed in 1.0 mL of H2O with EDC–NHS (20 mg–20 mg), and
the mixture was sonicated for 30 min at room temperature.
Aer magnetic separation, the obtained precipitate was added
to NTA (30mg) aqueous solution (1.0 mL). Themixture was then
stirred mechanically at room temperature for 24 h, followed by
magnetic separation. The obtained Fe3O4-NTA nanoparticles
were added to NiCl2 (0.1 M) aqueous solution (1.0 mL) and
reacted for another 1 h at room temperature. Aer magnetic
separation, the collected Fe3O4–NTA–Ni
2+ nanoparticles were
washed twice and redispersed in PBS for further use.
2.8 Expression and purication of His-tagged proteins in E.
coli
The gene for expression of green uorescent protein (GFP) was
cloned in PET-32a vector containing a full-length mutant
streptopain cDNA V334A with 6-His tagged on the N-terminal
end, and transformed into E. coli BL21 (DE3) cells. The BL21
(DE3) cells were grown in LB medium (10 g L1 tryptone, 5 g L1
yeast extract, and 10 g L1 NaCl) until OD600 reached 0.8, and
0.4 mM IPTG was then added to the culture and induced for 6 h
at 30 C. The bacterial cells were collected by centrifugation
with 6000 rpm at 4 C, and subsequently re-dispersed in 1.0 mL
of PBS (pH 7.4) with 1.0 mM PMSF. Aer disrupting the cell by
sonication on ice for 12 s, the cell lysate was centrifuged (10 000
rpm, 20min, 4 C) to remove the crude precipitates before being
subject to further protein purication.
2.9 Capacity and efficiency of the nanoparticles for
separation of His-tagged proteins
50 mg of His-tagged GFP was incubated with 100 mg of Fe3O4–
NTA–Ni2+ nanoparticles in 200 mL of PBS (pH 7.4) on ice for 30This journal is ª The Royal Society of Chemistry 2013min. To release the captured proteins, the nanoparticles were
then separated by a magnet, and incubated with various
concentrations of imidazole solution for 30min. To evaluate the
capability of Fe3O4–NTA–Ni
2+ nanoparticles for His-tagged GFP,
the released protein solution was diluted by 1.0 mL of PBS, and
the uorescent intensity of the solution was detected with a
uorescence spectrophotometer (the excitation wavelength was
488 nm) at room temperature. The derived proteins were also
visualized on SDS-PAGE aer electrophoresis and Coomassie
Brilliant Blue G-250 staining.3 Results and discussion
3.1 Synthesis and structure characterization of Fe3O4
nanoparticle
Fig. 1A–D show representative TEM images of the as-synthe-
sized Fe3O4 nanoparticles with diameters of 3.1  0.4 nm, 1.9 
0.4 nm, 4.2  0.7 nm and 13.8  1.5 nm, respectively. The low-
magnication TEM image of 3.1 nm Fe3O4 nanoparticles
(Fig. 1A) clearly shows their good monodispersity and high
dispersity. The histograms of particle size based on statistical
analysis over 200 particles are shown in Fig. 1A–D (inset),
demonstrating the high monodispersity of the Fe3O4 nano-
particles prepared by the current procedure. SAED (Fig. 1A,
inset) reveals that the nanoparticles are of high crystallinity.
HR-TEM analysis indicates that each particle is a well-ordered
single-domain crystal (Fig. 1E). Measured distances between
two adjacent lattice fringes gives a value of 0.253 nm, corre-
sponding to the lattice spacing of (311) planes of a face-centered
cubic (fcc) lattice of Fe3O4.3
The crystalline structures and phase composition of as-
synthesized Fe3O4 nanoparticles were further determined by
XRD. As shown in Fig. 2, all the diffraction peaks are indexed to
the spinel structure known for the Fe3O4 crystal (JCPDS card no.
01-082-1533) and no other peaks are detected, indicating that
the products are pure phase Fe3O4. In addition, the average
particle sizes calculated from the breadth of the (311) reection
using Debye–Scherrer's formula25 are 2.0, 3.3, 4.5 and 14.5 nm
for the as-synthesized Fe3O4 nanoparticles, respectively, which
are in good agreement with the TEM images (Fig. 1).Nanoscale, 2013, 5, 2133–2141 | 2135
Fig. 2 XRD patterns of Fe3O4 nanoparticles with diameters of (a) 1.9 nm, (b) 3.1













































View Article OnlineAs magnetite (Fe3O4) and maghemite (g-Fe2O3) exhibit
similar XRD patterns, the composition of the as-synthesized
nanoparticles was further identied by XPS, which is sensitive
to ferrous and ferric cations.26 Fig. 3A shows the representative
XPS spectra of the as-synthesized 3.1 nm-sized Fe3O4 nano-
particles. The Fe 2p high-resolution XPS pattern in Fig. 3B
reveals that the binding energy values of Fe 2p3/2 and Fe 2p1/2
are 710.8 and 724.6 eV, respectively, close to the published
literature about Fe3O4 nanoparticles.27,28 Furthermore, the
absence of a satellite at 719.0 eV could further identify that
nanoparticles produced by the current process are Fe3O4 rather
than g-Fe2O3.293.2 The surface composition of Fe3O4 nanoparticles
In order to further explore the surface properties of the as-
synthesized Fe3O4 nanoparticles, we characterized the Fe3O4Fig. 3 (A): XPS full spectrum; (B–D): high-resolution Fe2p, C1s, and O1s XPS
spectra of the 3.1 nm-sized Fe3O4 nanoparticles.
2136 | Nanoscale, 2013, 5, 2133–2141nanoparticles through x-potential analysis. As Na3Cit concen-
tration increased from 5 to 40 mM in the system, the x-potential
of the Fe3O4 nanoparticles signicantly decreased from 18.6
to 38.7 mV, demonstrating the increase of negative charge
density on the surface of the Fe3O4 nanoparticles. Considering
the strong complexation of the citrate groups with the Fe(III)
ions, the citrate groups may anchor on the nanoparticle surface
during the solvothermal reaction. It is thus suggested that the
increase of negative charge might be attributed to an increasing
amount of citrate groups on the surface of particles as Na3Cit
concentration increases in the current system.
Further direct proof for the presence of a coordinative effect
in the iron(III)-carboxylate group is obtained from FTIR, XPS and
TGA. The FT-IR spectra of Fe3O4 nanoparticles obtained with
Na3Cit concentrations over a range of 5–40 mmol L
1 (Fig. 4)
show absorption bands at 1652 and 1396 cm1, which are
assigned to the stretching vibrations of carboxyl salt. In addi-
tion, the peaks at 2856 and 2921 cm1 are attributed to the
vibrations of the symmetric and asymmetric stretching of the
methylene group, and the peak at 1050 cm1 is probably due to
the hydroxyl group from Na3Cit.30 In addition, the strong
absorption band at 581 cm1 is ascribed to n (Fe–O) in Fe3O4
nanoparticles, indicating that the main phase of the as-
synthesized nanoparticles is Fe3O4.28
The composition on the surface of the Fe3O4 nanoparticles
was further characterized by XPS spectra of C and O elements.
The high-resolution C1s spectrum (Fig. 3C) of Fe3O4 nano-
particles displays three peaks at 284.6, 286.2 and 288.4 eV,
which can be assigned to carbon atoms of aliphatic –C–C bonds,
–C–OH groups and –COO groups of citrate ions, respectively.31
The O1s spectrum (Fig. 3D) exhibits three peaks at 531.2, 532,
and 535.9 eV, corresponding to oxygen being present in three
different environments as Fe–O, O–C]O and O–H (due to the
adsorbed or coordinated water molecules), respectively.4 Both
the FTIR and XPS results thus demonstrate the existence of
carboxylate groups on the surface of the Fe3O4 nanoparticles.28Fig. 4 FTIR spectra of the Fe3O4 nanoparticles obtained with various Na3Cit
concentrations (mmol L1): (a) 5, (b) 10, (c) 20, and (d) 40. The other experimental
parameters remain constant ([FeCl3]: 100 mmol L
1, [NaOAc]: 300 mmol L1,
DEG: 40 mL, reaction temperature: 200 C, and reaction time: 10 h, respectively).













































View Article OnlineThe quantity of the carboxylate groups was then evaluated
from the weight lost in the TGA curves. As shown in Fig. 5, a
large weight loss of about 24 wt% in the range of 30–800 C is
seen for the 3.1 nm-sized Fe3O4 nanoparticles. In contrast, a
weight loss of only 10.0 wt% is observed for the Fe3O4 nano-
particles obtained without addition of Na3Cit. It is thus
demonstrated that considerable amounts of carboxyl salt bind
to the surface of the Fe3O4 nanoparticles. In addition, the
weight loss increases observably as the amount of Na3Cit
increases (Fig. 5), demonstrating that more Na3Cit binds to the
surface of the as-synthesized Fe3O4 nanoparticles.3.3 Effects of the reaction conditions on the particle size of
the Fe3O4 nanoparticles
The effects of the reaction conditions on the grain size and
particle size of the as-synthesized Fe3O4 nanoparticles were
further investigated. The products prepared at a lower temper-
ature (<200 C) showed no magnetic response (data not shown),
indicating that 200 C is a critical temperature for the synthesis
of Fe3O4 nanoparticles when DEG is utilized as a reductant.
When the reaction temperature was 200 C, the size of the as-
synthesized Fe3O4 nanoparticles increased from 1.9 to 4.2 nm as
the reaction time was prolonged from 4 h to 10 h (Fig. 1B and C).
Furthermore, as the reaction temperature was increased from
200 to 240 C, the size of the as-synthesized Fe3O4 nanoparticles
increased signicantly from 3.1 to 13.8 nm (Fig. 1A and D) when
the other experimental parameters were kept constant, indi-
cating that the effect of reaction temperature on the nano-
particle size is more noticeable than reaction time.
In addition, both NaOAc and Na3Cit play important roles in
the formation of ultra-small, water soluble Fe3O4 nanoparticles
in the current system. Herein, NaOAc is used as an alkali source.
When the other parameters were kept constant ([FeCl3]: 100
mmol L1, [Na3Cit]: 40 mmol L
1, DEG: 40 mL, reaction
temperature: 200 C, and reaction time: 10 h), the grain sizeFig. 5 TGA curves of Fe3O4 nanoparticles obtained with various Na3Cit
concentrations: (a) 0, (b) 5, (c) 10, (d) 20 and (e) 40 mmol L1. The other exper-
imental parameters remain constant ([FeCl3]: 100 mmol L
1, [NaOAc]: 300 mmol
L1, DEG: 40 mL, reaction temperature: 200 C, and reaction time: 10 h,
respectively).
This journal is ª The Royal Society of Chemistry 2013slightly increased from 3.9 to 5.4 nm with an increase in
concentration of NaOAc from 150 to 450 mmol L1 (Fig. 6A).
Furthermore, no Fe3O4 nanoparticles could be found in the
absence of NaOAc. These results agree that the hydrolysis rate of
FeCl3 is promoted by increasing alkalinity which is benecial to
obtain larger grain sizes.31,32 However, when the amount of
NaOAc was kept constant ([NaOAc]: 300 mmol L1, [FeCl3]: 100
mmol L1, DEG: 40 mL, reaction temperature: 200 C, and
reaction time: 10 h) in the current system, the diffraction peaks
broadened obviously with increasing amount of Na3Cit
(Fig. 6B). Namely, as the initial Na3Cit concentration increased
from 5 to 40 mM, the grain sizes decreased dramatically from
7.4 to 4.5 nm. It is thus concluded that Na3Cit could act as a
stabilizer, which might signicantly suppress the grain growth
of the as-synthesized Fe3O4 nanoparticles.
3.4 Possible mechanism
A probable mechanism which leads to the resulting Fe3O4
nanoparticles is proposed as follows. First, when Na3Cit is
introduced to the FeCl3–DEG solution, a signicant amount of
Fe(II)–citrate or Fe(III)–citrate complex is formed. Sodium acetate
is then added and utilized as an alkali source. In the presence of
DEG and Na3Cit, Fe3O4 crystallites form rstly under alkaline
condition, followed by further growth into Fe3O4 nanoparticles
as the reaction time is prolonged in this system.19 In addition,
because of the strong coordination between Fe(III) ions and
carboxylate, the as-synthesized Fe3O4 nanoparticles also
possess a coating of Na3Cit.18 By increasing the amount of
Na3Cit, more citrate groups can bind to the surface of Fe3O4
nanoparticles through the strong coordinating ligand. This
results in a decrease of the size of Fe3O4 nanograins and makes
the Fe3O4 nanoparticles more stable. Additionally, the grain size
can be tuned slightly by changing the alkalinity of solution or by
varying the amount of NaOAc. The hydrolysis rate of FeCl3 can
be accelerated by increasing alkalinity so as to promote the
formation of larger Fe3O4 nanocrystals,33 which is further sup-
ported by our current results (Fig. 6A).
3.5 Colloidal stability of the as-synthesized Fe3O4
nanoparticles
Colloidal stability is one of the most important issues for the
nal biological application of the studied material. Herein, weFig. 6 (A): XRD patterns of the Fe3O4 nanoparticles obtained with different
concentrations of NaOAc: (a) 150, (b) 300, and (c) 450 mmol L1, respectively; (B):
XRD patterns of the Fe3O4 nanoparticles obtained with different concentrations
of Na3Cit: (a) 40, (b) 20, (c) 10, and (d) 5 mmol L
1, respectively. The other
experimental parameters for (A) and (B) are indicated in the text.













































View Article Onlineevaluated the stability of the as-synthesized Fe3O4 nanoparticles
at different pH values and biological buffers. The x-potential
and hydrodynamic size variation as a function of the pH are
represented in Fig. 7. It has been reported that common Fe3O4
nanoparticles lack stability in the range of physiological pH,
because their isoelectric point is around pH 7.0.24 As shown in
Fig. 7A, the isoelectric point of the as-synthesized Fe3O4 nano-
particles has been shied down to 2.0. In addition, at a pH
higher than 3.5, the citrate anions are negatively charged and no
longer neutralized by the protons of the medium, ensuring the
electrostatic repulsion between the particles. The hydrody-
namic diameter of the Fe3O4 nanoparticles (Fig. 7B) represents
a similar trend, being equal to 8 nm for pH > 3.5, whereas it is
signicantly higher at lower pH. Hence, the Fe3O4 nanoparticles
synthesized by this procedure are extremely stable and highly
negatively charged at neutral to basic pH values and are
extremely stability under ambient conditions, without showing
any precipitation even aer several months (Fig. 7B, inset). This
high stability is likely due to the considerable amounts of citrate
ions on the surface of the Fe3O4 nanoparticles, resulting in a
highly negative surface charge and a large electrostatic repul-
sion effect.
Furthermore, we evaluated the colloid stability of the as-
synthesized 3.1 nm-sized Fe3O4 nanoparticles in different buffer
solutions by monitoring the x-potential and hydrodynamic
diameters. As shown in Fig. 7C and D, the as-synthesized Fe3O4
nanoparticles were stable in PBS with a low concentration.
Namely, as the PBS (pH 7.4) concentration increased to 2, the
absolute x-potential value of the as-synthesized Fe3O4 nano-
particles in PBS decreased to 20 (Fig. 7C), meanwhile, the
hydrodynamic diameter (Fig. 7D) slightly increased from 8 nm
to 12 nm. Note that the absolute x-potential values of the as-
synthesized Fe3O4 nanoparticles in Tris-HCl and NaCl solutions
are over 30 (Fig. 7C), and the hydrodynamic diameter of the as-
synthesized Fe3O4 nanoparticles (8 nm, Fig. 7D) are moreFig. 7 Variation of x-potentials and hydrodynamic diameters as a function of: pH
(A and B) and buffer solution (C and D) for the as-synthesized 3.1 nm-sized Fe3O4
nanoparticles.
2138 | Nanoscale, 2013, 5, 2133–2141stable in Tris-HCl or NaCl solutions. It is thus reasonable to
assume that the stability of the as-synthesized Fe3O4 nano-
particles in the biological buffer solution will be benecial for
increasing the blood half-life by avoiding uptake by the reticu-
loendothelial system (RES), as they are being used for in vivo
bio-application.13,34
3.6 Magnetic properties of the as-synthesized Fe3O4
nanoparticles
The magnetic behavior of Fe3O4 nanoparticles is of importance
for practical applications. To normalize the saturation moment
of as-synthesized Fe3O4 nanoparticles, the element content of
Fe for each sample was detected by ICP-MS analysis, which
indicates that the weight percentages of Fe3O4 for 1.9, 3.1, 4.2
and 13.8 nm-sized as-synthesized nanoparticles are 61.4, 64.1,
59.4, and 85.45%, respectively. The normalized M–H curves
shown in Fig. 8A, indicate that all the as-synthesized Fe3O4
nanoparticles exhibit superparamagnetic properties at room
temperature, and their magnetic properties are size-dependent.
The normalized saturation moment of the 1.9, 3.1, 4.2 and 13.8
nm-sized Fe3O4 nanoparticles are 4.54, 13.67, 31.98 and 82.61
emu g1, respectively. The signicant decrease of the magneti-
zation as the particle size decreases can be explained by two
main reasons. First, the lack of full alignment of the spins in the
surface atoms could result in the spin canting effect, which is
responsible for the low magnetization of small-sized magnetic
nanoparticles. Second, Fe3O4 nanoparticles could be regarded
as core–shell structures composed of magnetic cores and
magnetically disordered shells.14 As the nanoparticle size
decreases, especially for nanoparticles smaller than 2 nm, the
magnetic core shrinks signicantly while the magnetically
disordered shell increases. This causes the sharp decrease in
the magnetization of the as-synthesized Fe3O4 nanoparticles. In
our work, as the nanoparticle size decreases from 13.8 to
1.9 nm, the magnetization at room temperature tends to
decrease evidently from 82.61 to 4.54 emu g1. It thus makes it
possible for the Fe3O4 nanoparticles to be used as T1 contrast
agents, because the low magnetic moment favors suppressing
the T2 effects and maximizing the T1 contrast effects.
3.7 Relaxometric properties of the as-synthesized Fe3O4
nanoparticles
To examine the possibility of using the as-synthesized Fe3O4
nanoparticles as a T1 MRI contrast agent, the relaxation time of
the Fe3O4 nanoparticles wasmeasured with a 7.0 T small animal
MR scanner. Fig. 8B shows the T1 weighted MR images of
1.9 nm-sized Fe3O4 nanoparticles at different Fe ions concen-
trations. The bright signal enhancement progressively increases
with increasing Fe3O4 nanoparticle concentration, thus mani-
festing their potential application as T1 contrast agents. To
further investigate the contrast effect, the specic relaxivities (r1
or r2) of the as-synthesized Fe3O4 nanoparticles were investi-
gated. As shown in Fig. 8C and Table 1, the smaller the size of
the Fe3O4 nanoparticles, the higher the r1 relaxivity is in the T1-
weighted MR images, which indicates that the T1 shortening
effect increases as the size of the nanoparticles decreases. The r2This journal is ª The Royal Society of Chemistry 2013
Fig. 8 (A). Normalized field-dependent magnetization curves (M–H) at 300 K for Fe3O4 nanoparticles with diameters of 1.9, 3.1, 4.2, and 13.8 nm, respectively; (B). T1
weighted MR images of 1.9 nm-sized Fe3O4 nanoparticles at different concentration of Fe; (C). Plot of 1/T1 over Fe concentration of Fe3O4 nanoparticles. The slope













































View Article Onlinevalues of 1.9, 3.1, 4.2 and 13.8 nm-sized nanoparticles are 2.87,
11.41, 37.04 and 94.71 mM1 s1, respectively. Because of the
weak magnetic inhomogeneity resulting from low magnetic
moment, the Fe3O4 nanoparticles (<4 nm) exhibit low T2 relax-
ivity as compared to the larger sized particles. Furthermore, the
ratio r2/r1 is an important indicator whether the Fe3O4 nano-
particles can be employed as T1 contrast agents or not. As shown
in Table 1, the r2/r1 ratios of 1.9, 3.1, 4.2 and 13.8 nm-sized
nanoparticles are 2.03, 13.57, 111.56 and 488.19, respectively.
Especially for the 1.9 nm-sized Fe3O4 nanoparticles, the r2/r1
ratio decreases dramatically to 2.03, in accordance with
common paramagnetic chelates such as Gd–DTPA.35 It is thus
demonstrated that the as-synthesized 1.9 nm-sized Fe3O4
nanoparticles can be efficient T1 contrast agents.3.8 The cytotoxicity of as-synthesized Fe3O4 nanoparticles
To examine the feasibility of using the Fe3O4 nanoparticles in
bio-related elds, the cellular viability of HeLa cells with
different concentrations of the Fe3O4 nanoparticles was tested
(Fig. 9). Notably, the 3.1 nm-sized Fe3O4 nanoparticles exhibited
a negligible cytotoxic prole even aer 24 h. Furthermore, over
80% cell viability was obtained when the concentration was
increased to 2.00 mg mL1. Similar results were obtained when
the other sized Fe3O4 nanoparticles were tested for the cyto-
toxicity analysis (data not shown). It is thus speculated that the
as-synthesized Fe3O4 nanoparticles could exhibit good
biocompatibility and might be practicable in bio-related





1.9 1.415 2.87 2.03
3.1 0.841 11.41 13.57
4.2 0.332 37.04 111.56
13.8 0.197 94.71 488.19
This journal is ª The Royal Society of Chemistry 20133.9 Fe3O4–NTA–Ni
2+complex for efficient protein separation
By utilization of the high saturation magnetization and high
dispersibility, the as-synthesized Fe3O4 nanoparticles can be
easily modied further for various biomedical applications. In
this work, the separation capacity of His-tagged proteins by
13.8 nm-sized Fe3O4 nanoparticles was also investigated by
using GFP as a model protein. Fe3O4 nanoparticles were rstly
modied with NTA by using EDC/NHS methods, and subse-
quently chelating Ni2+ to form the Fe3O4–NTA–Ni
2+ complex,
which is employed to separate the His-tagged proteins. The
specicity of Fe3O4–NTA–Ni
2+ nanoparticles binding with His-
tagged GFP was analyzed by SDS-PAGE (Fig. 10A). As a control,
the amount of His-tagged GFP released from Fe3O4–NTA
nanoparticles was almost negligible (Fig. 10A, lanes 3), indi-
cating that His-tagged GFP bond to the Fe3O4–NTA–Ni
2+ nano-
particles not by the physical absorption. Aer the incubation of
the His-tagged GFP-captured nanoparticles with concentrated
imidazole solutions, the elution solution contained lots of His-
tagged GFP (Fig. 10A, lanes 4–7). Moreover, when the His-tagged
GFP-captured nanoparticles were incubated with a higher
concentration of imidazole solution, more His-tagged GFP wasFig. 9 The in vitro cell viability of HeLa cells incubated with different concen-
trations of 3.1 nm-sized Fe3O4 nanoparticles for 12 and 24 h, respectively.
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Fig. 10 (A). SDS-PAGE analysis of proteins: lane 1: marker; lane 2: His-tagged
GFP; lane 3: the fraction washed off from the Fe3O4–NTA nanoparticles; lanes 4–
7: the fraction washed off from the Fe3O4–NTA–Ni
2+ nanoparticles with different
concentration of imidazole (5, 50, 100 and 500 mM, respectively). (B). Fluores-














































View Article Onlinereleased from the surface of nanoparticles. It is thus further
demonstrated that His-tagged GFP could be adsorbed on the
surface Fe3O4–NTA–Ni
2+ nanoparticles through a coordination
interaction between His tags and nickel ions, rather than the
physical adsorption effects.
To quantify the protein separation efficacy, the uorescent
intensities of His-tagged GFP before and aer incubation with
Fe3O4–NTA–Ni
2+ nanoparticles were also measured (Fig. 10B).
Aer incubation with Fe3O4–NTA–Ni
2+ nanoparticles, the uo-
rescence intensity of the His-tagged GFP solutions was reduced
to 20.2% of the initial intensity, indicating the signicant
binding of His-tagged GFP on Fe3O4–NTA–Ni
2+ nanoparticles.
The incubation of the His-tagged GFP-captured nanoparticles
with concentrated imidazole solution might cause the proteins
to be released from the Fe3O4–NTA–Ni
2+ nanoparticles, result-
ing in a 72.5% recovery of the uorescent emission intensity
related to that of the original GFP. It is thus suggested that the
as-synthesized Fe3O4–NTA–Ni
2+ nanoparticles might have
excellent binding efficiency and recovery efficiency for His-tag-
ged protein, making the as-synthesized Fe3O4 nanoparticles
promising for potential applications.4 Conclusions
In summary, monodisperse, ultra small and water-soluble
Fe3O4 nanoparticles have been successfully synthesized via a
simple one-pot reaction. The as-synthesized Fe3O4 nano-
particles not only show excellent colloidal stability in different
buffer solutions, but also exhibit good biocompatibility in vitro.
Thus, the as-synthesized Fe3O4 nanoparticles might have a wide
variety of potential biomedical applications. Herein, it is
demonstrated that the 1.9 nm-sized Fe3O4 nanoparticles could
be employed as potential T1 contrast agents in vitro, and the
13.8 nm-sized Fe3O4 nanoparticles can be further modied and
used as magnetic carriers for protein separation.Acknowledgements
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